Glaxosmithkline



Ebit Changement Date
AbbVie USD 5.65B 407M 2025-03
Amgen USD 3.6B 434M 2025-03
AstraZeneca USD 4.8B 604M 2025-03
Aurora Cannabis CAD 36.86M 39.25M 2024-12
Bausch Health Companies USD 587M 41M 2025-03
Bristol-Myers Squibb USD 4.18B 30M 2025-03
Canopy Growth CAD -23822000 22.12M 2024-12
Corcept Therapeutics USD 3.42M 21.85M 2025-03
Drreddys Laboratories INR 18.02B 1.22B 2024-12
Eli Lilly USD 3.7B 1.93B 2025-03
GlaxoSmithKline GBP 2.53B 1.1B 2025-03
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Indivior 71M 30M 2025-03
J&J USD 7.39B 2.04B 2025-03
Merck USD 5.22B 339M 2024-12
Novartis USD 4.86B 286M 2024-12
Pacira USD 56.14M 7.23M 2024-12
Perrigo USD 146.6M 47.3M 2025-03
Pfizer USD 5.93B 1.31B 2025-03
Prestige Brands USD 100.89M 8.93M 2025-03
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 2.9B 824M 2025-03
Supernus Pharmaceuticals USD 48.3M 19.4M 2024-12
Takeda JPY 58B 129.82B 2024-12
Teva Pharmaceutical Industries USD 946M 222M 2025-03
Zoetis USD 909M 79M 2025-03



Glaxosmithkline - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.